Align Technology Invests ₹1,800 Crore for First India Plant in Hyderabad

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorIshaan Verma|Published at:
Align Technology Invests ₹1,800 Crore for First India Plant in Hyderabad
Overview

Align Technology, a leading medical device company, is investing ₹1,800 crore to open its first manufacturing plant in Hyderabad, India. This new facility will create over 300 jobs and increase the global supply of Invisalign clear aligners. It is expected to start operations by 2027 and will use advanced 3D printing and digital technologies.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Align Technology Expands Global Manufacturing to Hyderabad

Align Technology, known for its Invisalign clear aligners, is expanding its manufacturing capabilities by opening its first production facility in India. The company will invest ₹1,800 crore to build a new plant in Hyderabad, Telangana. This will be Align Technology's fourth global manufacturing site, with operations expected to begin in 2027. The facility is anticipated to create more than 300 jobs.

Boosting Production and Technology

The Hyderabad plant will significantly contribute to Align Technology's global manufacturing efforts, which currently produce nearly one million clear aligner parts daily. The facility will utilize advanced 3D printing, automated processes, and digital technologies to meet rising worldwide demand. This expansion complements Align Technology's existing operations in Hyderabad, including its Global Capability Centre and the Align Innovation Center.

Financial Performance and Market Position

Align Technology reported revenues of about $1.04 billion in the first quarter of 2026. As of May 17, 2026, its P/E ratio was 26.38, well below its 10-year median. The company's market capitalization stood at approximately $11.67 billion as of May 21, 2026. Key competitors include Envista Holdings Corporation and Dentsply Sirona. Despite a strong global market share of 75-85% in clear aligners, patent expirations have increased competition. Align Technology has seen revenue growth of 2.3% over the past two years, though rising expenses have affected its operating margin, suggesting potential pressure on profits.

Strategic Importance for Telangana

This investment highlights Telangana's growing role as a center for advanced manufacturing and medical technology. The state government sees this as a significant boost for Hyderabad's life sciences sector. The new facility is expected to enhance the region's MedTech and precision manufacturing ecosystem, reflecting confidence in Telangana's infrastructure, workforce, and business policies for advanced industries.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.